EPA-Approved SARS-CoV-2 Disinfectants

15 rows where "Date_on_List_N" is on date 2021-04-13 sorted by Formulation_type

Export this Data | Chart Risk Level by Product  Clear Chart

Add More Filters: Active_ingredient, Contact_time, Formulation_type,

Risk_level

Use_site (array)

Date_on_List_N (date)

  • 2021-04-13 · 15

 

ID EPA_reg_num Risk_level Active_ingredient Product_name Company Use_site Surface_type Contact_time Formulation_type ▼ Date_on_List_N Why_on_List_N
1099 6836-136 Increased Risk Quaternary ammonium Lonza Formulation S-18F Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1100 6836-140 Increased Risk Quaternary ammonium Lonza Formulation S-21F Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1102 6836-77 Increased Risk Quaternary ammonium Lonza Formulation S-18 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1103 6836-381 Increased Risk Quaternary ammonium Lonzagard R-82G Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1104 6836-139 Increased Risk Quaternary ammonium Lonza Formulation R-82F Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1109 6836-75 Increased Risk Quaternary ammonium Lonza Formulation S-21 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1110 6836-78 Increased Risk Quaternary ammonium Lonza Formulation R-82 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1092 6836-442 Safer Hydrogen peroxide DS6835 Arxada, LLC Healthcare; Institutional Hard Nonporous (HN) 0.5 minutes Ready-to-use; Electrostatic Spray 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1076 70627-56 Safer Hydrogen peroxide Oxivir™ Tb Diversey Inc Healthcare; Institutional Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) 1.0 minutes Ready-to-use; Electrostatic spray 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1101 6836-152 Increased Risk Quaternary ammonium Lonza Formulation DC-103 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Ready-to-use 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1225 1130-15 Increased Risk Quaternary ammonium; Isopropanol (Isopropyl alcohol) Weiman Germicidal Solution Weiman Products LLC Healthcare; Institutional; Residential Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) 2.0 minutes Ready-to-use 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1228 70144-1 Increased Risk Quaternary ammonium; Isopropanol (Isopropyl alcohol) Opti-Cide 3® Micro-Scientific LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 2.0 minutes Ready-to-use 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1292 70271-34 Increased Risk Quaternary ammonium KIK Antibacterial Multipurpose Cleaner I KIK International LLC Healthcare; Institutional; Residential Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) 10.0 minutes Ready-to-use 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1085 42182-13 Increased Risk Quaternary ammonium; Ethanol (Ethyl alcohol) Ironman Wipe Microban Products Company Healthcare; Institutional; Residential Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) 0.1 minutes Wipe 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1540 67071-123 Increased Risk Quaternary ammonium Acticide C&D 09 Wipes Thor Specialties Inc Healthcare; Institutional; Residential Hard Nonporous (HN) 0.25 minutes Wipe 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim

Export This Data

CSV options:

JSON shape: default, array, newline-delimited, object